Facet browsing currently unavailable
Page 1 of 2149 results
Sort by: relevance publication year
Potential and real drug interactions in patients treated with abiraterone or enzalutamide in clinical practice JOURNAL ARTICLE published 2 December 2021 in Expert Opinion on Drug Metabolism & Toxicology |
New drugs for chemotherapy-induced nausea and vomiting: focus on palonosetron JOURNAL ARTICLE published June 2005 in Expert Opinion on Drug Metabolism & Toxicology |
CNS pharmacokinetics of antifungal agents JOURNAL ARTICLE published August 2007 in Expert Opinion on Drug Metabolism & Toxicology |
Alterations in drug disposition during pregnancy: JOURNAL ARTICLE published August 2007 in Expert Opinion on Drug Metabolism & Toxicology |
Combination therapy of Western drugs and herbal medicines: recent advances in understanding interactions involving metabolism and efflux JOURNAL ARTICLE published August 2012 in Expert Opinion on Drug Metabolism & Toxicology |
Pharmacokinetic modelling and Bayesian estimation-assisted decision tools to optimize vancomycin dosage in neonates: only one piece of the puzzle JOURNAL ARTICLE published 2 September 2019 in Expert Opinion on Drug Metabolism & Toxicology |
Current strategies with eptifibatide and other antiplatelet agents in percutaneous coronary intervention and acute coronary syndromes JOURNAL ARTICLE published December 2005 in Expert Opinion on Drug Metabolism & Toxicology |
Valproate semisodium ER for migraine and cluster headache prophylaxis JOURNAL ARTICLE published April 2010 in Expert Opinion on Drug Metabolism & Toxicology |
Pharmacokinetic and pharmacodynamic considerations for the current chronic constipation treatments JOURNAL ARTICLE published April 2013 in Expert Opinion on Drug Metabolism & Toxicology |
JOURNAL ISSUE published June 2007 in Expert Opinion on Drug Metabolism & Toxicology |
Have physiologically-based pharmacokinetic models delivered? JOURNAL ARTICLE published August 2011 in Expert Opinion on Drug Metabolism & Toxicology |
Pharmacokinetic and toxicity considerations for the use of anthracyclines in ovarian cancer treatment JOURNAL ARTICLE published June 2011 in Expert Opinion on Drug Metabolism & Toxicology |
An update on chemotherapy and tumor gene expression profiles in breast cancer JOURNAL ARTICLE published September 2012 in Expert Opinion on Drug Metabolism & Toxicology |
Factors influencing hepatic metabolism of antihypertensive drugs: impact on clinical response JOURNAL ARTICLE published 2 January 2019 in Expert Opinion on Drug Metabolism & Toxicology Research funded by Secretaría de Ciencia y Técnica, Universidad de Buenos Aires (UBACyT 20020150100142BA) |
Potency and selectivity of vardenafil: a phosphodiesterase Type 5 inhibitor JOURNAL ARTICLE published August 2005 in Expert Opinion on Drug Metabolism & Toxicology |
Sildenafil: efficacy, safety, tolerability and mechanism of action in treating erectile dysfunction JOURNAL ARTICLE published August 2005 in Expert Opinion on Drug Metabolism & Toxicology |
Inhibition effect of epigallocatechin-3-gallate on the pharmacokinetics of calcineurin inhibitors, tacrolimus, and cyclosporine A, in rats JOURNAL ARTICLE published 2 January 2021 in Expert Opinion on Drug Metabolism & Toxicology Research funded by National Natural Science Foundation of China (818743426) | Chinese Medicine Research Project of Health Commission of Hubei Province (ZY2019Z004) | National Key R&D Program of China (2017YFC0909900) |
The role for microRNAs in drug toxicity and in safety assessment JOURNAL ARTICLE published 3 April 2015 in Expert Opinion on Drug Metabolism & Toxicology |
Pharmacokinetic modeling to determine the minimum effective dose of disease-specific antibodies for preventing hepatitis A post-exposure JOURNAL ARTICLE published 2 July 2020 in Expert Opinion on Drug Metabolism & Toxicology |
Rosiglitazone in Canada: experience in clinical practice JOURNAL ARTICLE published April 2009 in Expert Opinion on Drug Metabolism & Toxicology |